Search the Newsroom
Filter By
Showing 2481 - 2490 of 2926 results
CHOP Leads Child Safety Project through Toyota Collaborative Safety Research Center
The research will focus on how passengers move and brace themselves during crash avoidance maneuvers.
Simultaneously Weaker and Stronger? New Brain Research Begins to Makes Sense of a Longstanding Paradox
New research suggests that people with autism may simultaneously have conflicting differences in strength of brain network connections
3 CHOP Scientists Win Bayer Grants for Hemophilia Research
Three CHOP researchers recently won grants for their work on hemophilia from the Bayer Hemophilia Awards Program.
Dr. Katherine Dahlsgaard Named 2017 Psychology in Media Award Winner
Dr. Dahlsgaard Recognized by the Pennsylvania Psychological Association for her efforts to bring evidence-based psychology to the public through the media.
CHOP Experts Travel to Foshan, China
The multidisciplinary team from CHOP partnered with colleagues abroad to share knowledge and clinical expertise.
Doctors Investigate Sudden Paralysis in Kids
6ABC interviews a CHOP patient family and neurologist Sarah Hopkins, MD, about acute flaccid myelitis, a condition causing sudden paralysis in some kids.
CHOP Oncologist Chairs AACR Pediatric Cancer Predisposition Workshop
Since its inception in October 2016, the workshop has created recommendations for the 50 most common syndromes that predispose children to cancer and produced 16 position papers.
Five Years Later, First Pediatric Recipient of CAR T-Cell Therapy Remains Cancer-free
Five years after her T-cell therapy for ALL, Emily remains cancer-free. CHOP has since treated more than 170 patients in clinical trials that have seen a 93% remission rate.
Video Tours Help Families Transition to Outpatient Oncology Care
Newly created videos allow families to see the facilities’ interiors and better understand what will happen during an outpatient visit before their scheduled appointment.
FDA Committee Recommends Approving First Cell Therapy to Successfully Treat Cancer
The experimental, personalized cell therapy that amps up the patient's own immune system has passed a critical milestone in the path to full FDA approval.